stockrowCalumet, Inc.
CLMT Basic Materials Specialty Chemicals
Calumet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.1 billion, down 1.25% from fiscal 2024.
- Revenue
- +40.8%
- EPS
- +35.9%
- Free cash flow
- +450.7%
- Total debt
- −1.98%
Quarter to June 2026, against a year earlier
Follow CLMT
Alert me
Calumet, Inc. (CLMT) Total debt
Calumet, Inc.'s total debt at the end of fiscal 2025 was $2.4B, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $2.7B. Over the past ten years it has ranged from $1.2B (fiscal 2019) to $2.4B (fiscal 2025) — the current reading is the highest in ten years. Calumet, Inc. ranks 15th of 60 Specialty Chemicals companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $2.4B | 2.44% |
| FY2024 | $2.3B | 8.46% |
| FY2023 | $2.2B | 6.22% |
| FY2022 | $2.0B | 19.41% |
| FY2021 | $1.7B | 17.46% |
| FY2020 | $1.5B | 19.85% |
| FY2019 | $1.2B | (24.51%) |
| FY2018 | $1.6B | (19.46%) |
| FY2017 | $2.0B | (0.25%) |
| FY2016 | $2.0B | 17.49% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $2.7B | 3.41% |
| Mar 2026 | $2.6B | 10.23% |
| Dec 2025 | $2.4B | (1.35%) |
| Sep 2025 | $2.4B | (12.84%) |
| 42 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| CLMT Calumet, Inc. | $2.7B |
| FUL H. B. Fuller Company compare | $2.1B |
| AVNT Avient Corporation compare | $1.8B |
| ASH Ashland Inc. compare | $1.4B |
| CBT Cabot Corporation compare | $1.3B |
| PRM Perimeter Solutions, SA compare | $1.2B |
| SXT Sensient Technologies Corporation compare | $790.4M |
| HWKN Hawkins, Inc. compare | $229.0M |
| WDFC WD-40 Company compare | $86.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on CLMT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement